Director, Equity Research | Healthcare | Canaccord Genuity
Matt Bottomley joined Canaccord Genuity in 2015. He is an equity research analyst with a current focus on the cannabis industry (both in Canada and internationally) and alternative pharmaceuticals. Previously, Matt worked as a financial consultant in commercial litigations, preparing business valuations and damage quantification reports, with an emphasis on the Canadian pharmaceutical industry. Matt also spent five years in the Audit and Assurance group at PricewaterhouseCoopers, covering a variety of industries including manufacturing, real estate, automotive and healthcare. Matt is a Chartered Professional Accountant and Chartered Business Valuator and graduated from McMaster University with an Honours Bachelor of Commerce.